NeuroPace Insider Rakhi Kumar Files Form 4 on March 23, 2026

TL;DR

**NeuroPace insider Rakhi Kumar filed a Form 4, signaling a change in ownership.**

AI Summary

This Form 4 filing indicates that Rakhi Kumar, an insider at NeuroPace Inc., filed a statement of changes in beneficial ownership of securities on March 23, 2026, for a period ending March 20, 2026. While the filing itself doesn't detail specific transactions like buys or sells, it signals that an insider's ownership status has changed. This matters to investors because insider activity can sometimes be a signal of management's confidence (or lack thereof) in the company's future prospects, potentially influencing stock price.

Why It Matters

This filing signals a change in insider ownership for Rakhi Kumar at NeuroPace Inc., which can be an important indicator for investors tracking management's conviction in the company.

Risk Assessment

Risk Level: low — This filing is purely administrative, reporting a change in beneficial ownership, and does not inherently indicate a high risk.

Analyst Insight

A smart investor would note this administrative filing and then seek out the full Form 4 document to understand the specific nature of the change in beneficial ownership (e.g., a stock grant, sale, or purchase) before drawing any conclusions about NeuroPace Inc's prospects.

Key Players & Entities

• Kumar Rakhi (person) — Reporting person, an insider at NeuroPace Inc.
• NeuroPace Inc (company) — The issuer of the securities.
• 0001856296 (dollar_amount) — CIK for Kumar Rakhi
• 0001528287 (dollar_amount) — CIK for NeuroPace Inc

FAQ

Filing Documents

• wk-form4_1774298557.html (4)
• wk-form4_1774298557.xml (4) — 3KB
• 0001856296-26-000003.txt ( ) — 5KB

From the Filing

SEC FORM 4 SEC Form 4 FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 OMB APPROVAL OMB Number: 3235-0287 Estimated average burden hours per response: 0.5    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10. 1. Name and Address of Reporting Person * Kumar Rakhi (Last) (First) (Middle) C/O NEUROPACE, INC. 455 N. BERNARDO AVENUE (Street) MOUNTAIN VIEW CALIFORNIA 94043 (City) (State) (Zip) UNITED STATES (Country) 2. Issuer Name and Ticker or Trading Symbol NeuroPace Inc [ NPCE ] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) X Director 10% Owner Officer (give title below) Other (specify below) 2a. Foreign Trading Symbol 3. Date of Earliest Transaction (Month/Day/Year) 03/20/2026 6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person 4. If Amendment, Date of Original Filed (Month/Day/Year) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned 1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 03/20/2026 A 1,153 (1) A $ 13 19,160 D Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) 1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4) Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares Explanation of Responses: 1. These shares were issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. Remarks: /s/ Leah Akin, Attorney-in-Fact 03/23/2026 ** Signature of Reporting Person Date Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. * Form 4: SEC 1474 (03-26)

View Full Filing

View this 4 filing on SEC EDGAR